Literature DB >> 9396692

Microbiologic approaches for studying Campylobacter species in patients with Guillain-Barré syndrome.

I Nachamkin1.   

Abstract

Campylobacter jejuni is now considered to be the most common cause of bacterial diarrheal disease in the United States. Sufficient evidence exists to support the hypothesis that C. jejuni induces Guillain-Barré syndrome (GBS); however, many questions about the biology of the organism and host factors need to be answered. In order to study the role of C. jejuni and other Campylobacter species as a cause of GBS, isolates from patients with different forms of GBS and appropriate control populations must be obtained. To continue to study this association, research teams must have laboratory support for isolating and characterizing Campylobacter strains. This review summarizes current knowledge about the laboratory aspects of Campylobacter infection that may be pertinent to studies on GBS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396692     DOI: 10.1086/513789

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.

Authors:  M A Strid; J Engberg; L B Larsen; K Begtrup; K Mølbak; K A Krogfelt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Comparison of premier CAMPY enzyme immunoassay (EIA), ProSpecT Campylobacter EIA, and ImmunoCard STAT! CAMPY tests with culture for laboratory diagnosis of Campylobacter enteric infections.

Authors:  Paul A Granato; Li Chen; Iris Holiday; Russell A Rawling; Susan M Novak-Weekley; Tammy Quinlan; Kimberlee A Musser
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

3.  Heat-stable antigen serotyping of Campylobacter jejuni strains isolated from hospitalized children in Athens, Greece.

Authors:  Stylianos Chatzipanagiotou; Eleni Papavasileiou; Anthi Lakumenta; Antonia Makri; Chryssoula Nicolaou; Konstantinos Chantzis; Stamatios Manganas; Nicolaos Legakis
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 4.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

5.  Influence of silver nanoparticles on growth and health of broiler chickens after infection with Campylobacter jejuni.

Authors:  Krishna Prasad Vadalasetty; Charlotte Lauridsen; Ricarda Margarete Engberg; Radhika Vadalasetty; Marta Kutwin; André Chwalibog; Ewa Sawosz
Journal:  BMC Vet Res       Date:  2018-01-02       Impact factor: 2.741

6.  Campylobacter infection as a trigger for Guillain-Barré syndrome in Egypt.

Authors:  Thomas F Wierzba; Ibrahim Adib Abdel-Messih; Bayoumi Gharib; Shahida Baqar; Amina Hendaui; Ibrahim Khalil; Tarek A Omar; Hamed E Khayat; Shannon D Putnam; John W Sanders; Lai-King Ng; Lawrence J Price; Daniel A Scott; Robert R Frenck
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

7.  Genomic Relatedness, Antibiotic Resistance and Virulence Traits of Campylobacter jejuni HS19 Isolates From Cattle in China Indicate Pathogenic Potential.

Authors:  Xiaoqi Zang; Pingyu Huang; Jie Li; Xinan Jiao; Jinlin Huang
Journal:  Front Microbiol       Date:  2021-11-30       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.